Health-related quality of life of patients with overactive bladder receiving immediate-release tolterodine

  title={Health-related quality of life of patients with overactive bladder receiving immediate-release tolterodine},
  author={Andreas M. Pleil and Pat Ray Reese and Con J. Kelleher and Gary J. Okano},
  journal={The European Journal of Health Economics (HEPAC)},
Overactive bladder (OAB) imposes a burden on many aspects of a patient's life. The health-related quality of life (HRQOL) of OAB patients has been shown to be lower than healthy or control patients. A goal of successful treatment is to improve the HRQOL of OAB patients. With newer OAB treatments becoming available, HRQOL is an important outcome to measure. Thus, the objective of this study was to compare the HRQOL of patients being treated with tolterodine immediate-release (IR) versus placebo… CONTINUE READING
5 Citations
34 References
Similar Papers


Publications referenced by this paper.
Showing 1-10 of 34 references

Developing a specific HRQL instrument for overactive bladder ( abstract )

  • HP Drutz, RA Appell, D Gleason, I Klimberg, S Radomski
  • Value Health
  • 2000

Overactive bladder : epidemiology and impact on quality of life

  • TH Wagner, TW Hu
  • Patient Care , Winter
  • 2000

Tolterodine , an effective and well tolerated treatment for urge incontinence and other overactive bladder symptoms

  • K Conway, V Uzun, A Marrel, L Cardozo, C Kelleher, I Haye
  • Clin Drug Invest
  • 2000

Validation of King ’ s Health Questionnaire in patients with symptoms of overactive bladder ( abstract )

  • WH Rogers, H Wittink, A Wagner, D Cynn, DB Carr
  • Qual Life Res
  • 2000

Linguistic validation of the King ’ s Health Questionnaire ( KHQ ) in eight languages ( abstract )

  • L Coyne, J Schmier, T Hunt, R Corey, J Liberman, D Revicki
  • Value Health
  • 1999

Similar Papers

Loading similar papers…